4ITF image
Entry Detail
PDB ID:
4ITF
Keywords:
Title:
Crystal structure of the human vitamin D receptor ligand binding domain complexed with 1alpha,25-Dihydroxy-2alpha-[2-(1H-tetrazole-1-yl)ethyl]vitamin D3
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2013-01-18
Release Date:
2014-01-22
Method Details:
Experimental Method:
Resolution:
2.84 Å
R-Value Free:
0.25
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Vitamin D3 receptor
Mutations:DEL(165-215) mutant
Chain IDs:A
Chain Length:263
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Synthesis of 2 alpha-heteroarylalkyl active vitamin d3 with therapeutic effect on enhancing bone mineral density in vivo
ACS MED.CHEM.LETT. 4 671 674 (2013)
PMID: 24900728 DOI: 10.1021/ml400098w

Abstact

2α-Heteroarylethyl-1α,25-dihydroxyvitamin D3 analogues, which were designed to form a hydrogen bond between Arg274 of human vitamin D receptor (hVDR) and a nitrogen atom of the heteroaromatic ring at the 2α-position, were synthesized. Among them, 2α-[2-(tetrazol-2-yl)ethyl]-1α,25-dihydroxyvitamin D3 showed higher osteocalcin promoter transactivation activity in human osteosarcoma (HOS) cells and a greater therapeutic effect in ovariectomized (OVX) rats, osteoporosis model animals, on enhancing bone mineral density than those of active vitamin D3. X-ray cocrystallographic analysis of the hVDR-ligand complex confirms that the new hydrogen bond formation stabilized the complex.

Legend

Protein

Chemical

Disease

Primary Citation of related structures